HOSPITAL UNIVERSITARIO INFANTA SOFÍA
Departamento
Santiago
Moreno Guillén
Publicaciones en las que colabora con Santiago Moreno Guillén (23)
2023
-
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 6, pp. 1423-1432
-
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 20, pp. 18161-18171
-
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV
HIV Medicine, Vol. 24, Núm. 6, pp. 727-737
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Past and future of HIV infection. A document based on expert opinion
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 131-156
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain
Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684
2020
-
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study
The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 10, pp. 3004-3014
-
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study
AIDS Research and Therapy, Vol. 17, Núm. 1
-
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
2019
-
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
PLoS ONE, Vol. 14, Núm. 8
-
Durability of first-line antiretroviral regimens in the era of integrase inhibitors: A cohort of HIV-positive individuals in Spain, 2014-2015
Antiviral Therapy, Vol. 24, Núm. 3, pp. 167-175
-
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010–2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 9, pp. 580-587
-
Uso de recursos sanitarios y costes asociados al tratamiento antirretroviral de primera línea en españa en la era de los inhibidores de la integrasa
Pharmaceutical care España, Vol. 21, Núm. 2, pp. 86-109
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
2016
-
Executive summary: Prevención y tratamiento de infecciones oportunistas y otras coinfecciones en pacientes infectados por el VIH: mayo de 2015
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 517-523